Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TNYA compared with ANVS: revenue, margins and what each company keeps, and the suppliers and customers both name
TNYA
Tenaya Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ANVS
Annovis Bio, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
TNYA
Tenaya Therapeutics, Inc.
vs
ANVS
Annovis Bio, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
TNYA
Tenaya Therapeutics, Inc.
Change
0.36
▲
+1.00%
· post 0.37
· delayed
Mkt cap
$80.9M
Revenue
$1M
Q2 FY26
ANVS
Annovis Bio, Inc.
Change
1.07
▼
−0.49%
· post 1.10
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$46.0M
Revenue
—
vs
Compare
After hours
Nov 3 '26
delayed
TNYA
Tenaya Therapeutics, Inc.
vs
ANVS
Annovis Bio, Inc.
0.36
▲
+1.00%
post 0.37
delayed
Price
1.07
▼
−0.49%
post 1.10
delayed
$80.9M
Mkt cap
$46.0M
Q2 FY26
$1M
Revenue
—
Change
Change
TNYA
0.36
▲
+1.00%
vs
ANVS
1.07
▼
−0.49%
After hours
Nov 3 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
TNYA: latest quarter is a loss; flow not drawable. ANVS: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only TNYA
2
ALNY
Alnylam Pharmaceuticals
customer
—
California Institute for Regenerative Medicine (CIRM)
unlisted
supplier
Shared
0
No shared counterparties.
Only ANVS
1
—
Alzheimer's Disease Cooperative Study ("ADCS")
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TNYA, solid
ANVS, dashed